Morgan Stanley’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-170,902
| Closed | -$16.6M | – | 6904 |
|
|
2019
Q3 | $16.6M | Buy |
170,902
+64,913
| +61% | +$6.3M | ﹤0.01% | 1647 |
|
|
2019
Q2 | $10.9M | Sell |
105,989
-124,571
| -54% | -$12.8M | ﹤0.01% | 2068 |
|
|
2019
Q1 | $26.3M | Buy |
230,560
+31,694
| +16% | +$3.61M | 0.01% | 1252 |
|
|
2018
Q4 | $7.78M | Buy |
198,866
+41,031
| +26% | +$1.61M | ﹤0.01% | 2396 |
|
|
2018
Q3 | $8.61M | Sell |
157,835
-304,286
| -66% | -$16.6M | ﹤0.01% | 2562 |
|
|
2018
Q2 | $38.2M | Buy |
462,121
+72,744
| +19% | +$6.02M | 0.01% | 1073 |
|
|
2018
Q1 | $25.9M | Buy |
389,377
+217,978
| +127% | +$14.5M | 0.01% | 1431 |
|
|
2017
Q4 | $8.81M | Buy |
171,399
+108,100
| +171% | +$5.56M | ﹤0.01% | 2529 |
|
|
2017
Q3 | $5.64M | Buy |
63,299
+4,378
| +7% | +$390K | ﹤0.01% | 2841 |
|
|
2017
Q2 | $3.52M | Buy |
58,921
+659
| +1% | +$39.4K | ﹤0.01% | 3257 |
|
|
2017
Q1 | $3.11M | Sell |
58,262
-25,398
| -30% | -$1.35M | ﹤0.01% | 3395 |
|
|
2016
Q4 | $4.18M | Buy |
83,660
+35,942
| +75% | +$1.79M | ﹤0.01% | 3190 |
|
|
2016
Q3 | $2.87M | Buy |
47,718
+21,203
| +80% | +$1.27M | ﹤0.01% | 3194 |
|
|
2016
Q2 | $1.36M | Sell |
26,515
-107,883
| -80% | -$5.52M | ﹤0.01% | 3730 |
|
|
2016
Q1 | $3.97M | Sell |
134,398
-21,276
| -14% | -$628K | ﹤0.01% | 2743 |
|
|
2015
Q4 | $7.05M | Sell |
155,674
-717
| -0.5% | -$32.5K | ﹤0.01% | 2328 |
|
|
2015
Q3 | $6.53M | Sell |
156,391
-9,354
| -6% | -$390K | ﹤0.01% | 2401 |
|
|
2015
Q2 | $9.99M | Sell |
165,745
-45,726
| -22% | -$2.76M | ﹤0.01% | 2112 |
|
|
2015
Q1 | $16.4M | Buy |
+211,471
| New | +$16.4M | 0.01% | 1620 |
|